Amanote Research
Register
Sign In
MA16.08 Clinical Utility of Detecting ROS1 Genetic Alterations in Plasma
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.453
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
I. Dagogo-Jack
R. Nagy
L. Ferris
J. Lin
J. Gainor
R. Lanman
A. Shaw
Publisher
Elsevier BV
Related search
Utility of a Multiplex PCR Assay for Detecting Herpesvirus DNA in Clinical Samples
Journal of Clinical Microbiology
Microbiology
Genetic Alterations in Glioma
Cancers
Cancer Research
Oncology
Alterations of Plasma Apolipoprotein A-Iv Levels Under Various Clinical Conditions
The Journal of Japan Atherosclerosis Society
Detection of Genetic Alterations by MASA Method and Its Clinical Application.
Japanese Journal of Gastroenterological Surgery
Surgery
Gastroenterology
Plasma Methoxytyramine: Clinical Utility With Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
P2.03-016 Clinical Utility of Liquid Biopsy for Detecting EGFR T790M Mutation Is Very Limited
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Re: The Clinical Utility of Genetic Testing of Tissues From Pregnancy Losses
BJOG: An International Journal of Obstetrics and Gynaecology
Gynecology
Obstetrics
OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Hemorheological Alterations in Sickle Cell Anemia and Their Clinical Consequences – The Role of Genetic Modulators
Clinical Hemorheology and Microcirculation
Physiology
Cardiovascular Medicine
Hematology
Cardiology